Do Genetic Polymorphisms Modulate Response Rate and Toxicity of Cisplatin Associated With Radiotherapy in Laryngeal Squamous Cell Carcinoma?: A Case Report

Cisplatin (CDDP) plus radiotherapy (RT) has been used to treat advanced laryngeal squamous cell carcinoma (LSCC) patients. Single nucleotide polymorphisms (SNPs) may be responsible for differences in chemo/radiosensitivity and side effects in those patients. We reported an advanced LSCC patient, who...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes-Aguiar, Leisa, Visacri, Marília Berlofa, Nourani, Carolina Marques Lopes, Costa, Ericka Francislaine Dias, Nogueira, Guilherme Augusto Silva, Lima, Tathiane Regine Penna, Pincinato, Eder Carvalho, Moriel, Patrícia, Altemani, João Maurício Carrasco, Lima, Carmen Silvia Passos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602693/
https://www.ncbi.nlm.nih.gov/pubmed/25906090
http://dx.doi.org/10.1097/MD.0000000000000578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602693/
https://www.ncbi.nlm.nih.gov/pubmed/25906090
http://dx.doi.org/10.1097/MD.0000000000000578

Ejemplares similares